GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » General and Admin. Expense

G.Barekat Pharm (XTEH:BRKT1) General and Admin. Expense : IRR Mil (TTM As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. G.Barekat Pharm's General and Admin. Expense for the six months ended in Mar. 2017 was IRR401,003 Mil. G.Barekat Pharm does not have enough years/quarters to calculate the General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2017.


G.Barekat Pharm General and Admin. Expense Historical Data

The historical data trend for G.Barekat Pharm's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm General and Admin. Expense Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
General and Admin. Expense
352,810.00 401,003.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
General and Admin. Expense 352,810.00 401,003.00

G.Barekat Pharm General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.


G.Barekat Pharm General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines